Childs BG, Gluscevic M, Baker DJ, Laberge RM, Marquess D, Dananberg J, van Deursen JM
The FDA approved semaglutide for chronic weight loss management in adults with a body mass index (BMI) of 30 kg/m2 or higher or those with a BMI of 27 kg/m2 or higher and at least one weight-related ailment, such as high cholesterol, high blood pressure, or type 2 diabetes
Biochemical parameters related to intestinal digestion and absorption function included trypsin, chymotrypsin, lipase, amylase, alkaline phosphatase (AKP), sodiumpotassium adenosine triphosphatase (Na/K-ATPase), gamma-glutamyl transferase (-GT), and creatine kinase (CK)
Most patients using injectable GHK-Cu for skin or hair notice early changes within 4 to 6 weeks
Traditionally, the medication was used to control blood sugar, making it a preferred treatment for type 2 diabetes
It works by mimicking the incretin hormones, enhancing insulin secretion, and reducing glucagon levels, which aids in controlling blood sugar